TechNode Event

Here are the Outstanding Ecosystem Leaders finalists for ORIGIN Innovation Awards 2022.

Wen Shuhao, the founder of AI-powered drug developer XTalPi, said, “the door for the digitalized drug industry, intelligent automation, and AI-driven drug development has opened.” Wen shared his views on how AI works in the process of drug research and development and discussed what startup they would invest in a fireside chat at the BEYOND Expo 2022.

Three tech entrepreneurs in the Web3 space discuss the core differences between Web3 and our current internet experience at a panel discussion that took place on Sept. 26 at the Beyond Expo 2022 tech conference, held online at BEYOND Metaverse.

Together with the all-star advisory team, TechNode Global spent close to two weeks evaluating every nomination and determining the finalists.

Three guests from Web3 and investment companies spoke with moderator ShinWei Teh, an Investment Banker at Credit Suisse, about whether Web3 investment is all hype or based on science, as well as how to evaluate the performance of Web3 companies and other Web3-relate questions at the BEYOND Expo 2022 tech conference, held online in BEYOND Metaverse.

As the world faces an array of challenges and consumers and citizens become ever more conscious of the social and environmental impact of the companies that dominate their lives, having a robust economic, social, and governance (ESG) policy in place has become an essential component for any company looking to IPO.

BEYOND Expo continues to strive for excellence as the international exhibition platform that provides an immersive experience to participants. We look forward to seeing you again at the BEYOND Expo 2023 in Macao.

Yat Siu, Animoca’s Co-Founder and Chairman, talked about why they are bullish on Web3 gaming and whether the play-to-earn gaming model is sustainable at the BEYOND Expo 2022 tech conference, held online at BEYOND Metaverse.

As many regions around the world enter an adjustment period, startup founders and investors have to adjust to a slower fundraising pace. Still, some investors see the adjustment as a healthy thing since it produces more reasonable valuations, weeds out unproductive firms, and forces founders to focus on creating real value.